drugset / Trial / NCT01607385
A Study to Evaluate the Safety, Tolerability, Pharmacokinetic a Single Day of Dosing With GSK1614235.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A single blind, randomized, placebo-controlled, dose escalating study to evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic parameters of repeat doses of GSK2330672 in healthy volunteers, given alone and with a single day of dosing with GSK1614235
Timeline
- Start
- 2012-05-18
- Primary completion
- 2012-12-03
- Completion
- 2012-12-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Linerixibat | Small molecule | — | — |
| Comparator | GSK1614235 | Unknown | — | — |